期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

HE4—一种新的卵巢上皮性癌肿瘤标记物的研究进展 被引量：7

下载PDF
导出
摘要 CA125是目前临床上广泛用于诊断卵巢上皮性癌的肿瘤标记物,然而其诊断卵巢上皮性癌的敏感性及特异性并不十分满意,因此,卵巢上皮性癌肿瘤标记物的研究成为近年妇瘤领域的一个热点。自从卵巢癌相关基因人附睾蛋白4(HE4)发现以来,国内外对HE4进行了一些相关研究,认为HE4有可能成为一个良好的卵巢上皮性癌的肿瘤标记物。现对HE4的结构、表达及其在卵巢上皮性癌的诊断、疗效评估等方面的进展做一综述。
作者 陈丽梅 章琼 刘琦 管群
机构地区 南京大学临床医学院 南京军区南京总医院妇产科
出处 《现代妇产科进展》 CSCD 北大核心 2010年第1期66-68,共3页 Progress in Obstetrics and Gynecology
关键词 人附睾蛋白4 CA125 卵巢肿瘤 肿瘤标记物
分类号 R711.75 [医药卫生—妇产科学]
  • 相关文献

参考文献20

  • 1任海花,任卫东,马惠风.卵巢癌临床流行病学调查报告[J].基层医学论坛,2009,13(2):62-63. 被引量：29
  • 2Pickle LW,Hao Y, Jemal A, et al. A new method of estimating United States and state-level cancer incidence counts for the current calendar year [ J ]. CA Cancer J Clin, 2007,57 : 30-42.
  • 3Drapkin R, Lin Y, Mok SC, et al. Human epididymis prorein 4( HFA ) is a secreted glycoprotein that is over expressed by serougt and endometrioid ovarian carcinomas [ J]. Cancer Res ,2005,65:2162-2169.
  • 4Bast Jr RC. Status of tumor markers in ovarian cancer screening [ J ]. J Clin Oncol.2003,21 : 200-205.
  • 5Piver MS, Baker TR, Driscoll DL. Lack of substantial five year disease-free survival by primary aggressive surgery and cisplatin-based chemotherapy or by salvage intraperitoneal cisplatin-based chemotherapy [ J ]. Eur J Gynaecol Oncol, 1990,11:243-250.
  • 6Hellstrom I, Raycraft J, Schummer M, et al. The HFA (WFDC2) protein is a biomarker for ovarian carcinoma [ J]. Cancer Res ,2003,63:3695-3700.
  • 7Kirchhoff C, Habben I, Ivell R, et al. A major human epididymis-specific cDNA encodes a protein with sequence homology to extracellular proteinase inhibitors [ J ]. Biol Reprod, 1991,45:350-357.
  • 8Kirchhoff C. Molecular characterization of epididymal proteins[ J]. Rev Reprod, 1998,3:86-95.
  • 9Sehummer M, Ng WV, Bumgarner RE, et al. Comparative hybridization of an array of 21500 ovarian cDNAs for the discovery of genes over expressed in ovarian carcinomas[ J ]. Gene, 1999,238 : 375-385.
  • 10Wang K, Gan L,Jeffrey E, et al. Monitoring gene expression profile changes in ovarian carcinomas using cDNA microarray [ J]. Gene, 1999,229 : 101-108.

二级参考文献31

  • 1周丰宁.血清CA125测定对子宫内膜异位症及子宫腺肌病的诊断价值[J].临床医学,2005,25(9):74-74. 被引量：15
  • 2Gadducci A, Cosio S, Carpi A, et al. Serum tumor markers in the management of ovarian, endometrial and cervical cancer. Biomed Pharmacother,2004,58 : 24 -38.
  • 3Meyer T, Rustin GJ. Role of tumour markers in monitoring epithelial ovarian cancer. Br J Cancer,2000,82 : 1535-1538.
  • 4Hellstrom I, Raycraft J, Hayden-Ledbetter M, et al. The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma. Cancer Res, 2003,63 : 3695 -3700.
  • 5Israeli O, Goldring-Aviram A, Rienstein S, et al. In sihco chromosomal clustering of genes displaying altered expression patterns in ovarian cancer. Cancer Genet Cytogenet,2005 ,160 :35- 42.
  • 6Drapkin R, von Horsten HH, Lin Y, et al. Human epididymis protein 4 ( HE4 ) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas. Cancer Res, 2005, 65:2162-2169.
  • 7Kirchhoff C, Habben I, Ivell R, et al. A major human epididymisspecific cDNA encodes a protein with sequence homology to extracellular proteinase inhibitors. Biol Reprod, 1991,45: 350- 357.
  • 8Moore RG, Brown AK, Miller MC, et al. The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass. Gynecol Oncol,2008,108:402-408.
  • 9Zhang Z, Barnhill SD, Zhang H, et al. Combination of multiple serum markers using an artificial neural network to improve specificity in discriminating malignant from benign pelvic masses. Gynecol Oncol, 1999,73:56-61.
  • 10Woolas RP, Xu FJ, Jacobs IJ, et al. Elevation of multiple serum markers in patients with stage I ovarian cancer. J Natl Cancer Inst, 1993, 85:1748-1751.

共引文献171

同被引文献60

  • 1Ozols RF,Bookman MA, Connolly DC, et al. Focus on epithelial ovarian cancer[J]. Cancer Cell, 2004,5 (1) : 19-24.
  • 2Hellstrom I, Raycraft J, Hayden-ledbetter M, et al. The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma[J].Cancer Res,2003,63(?) :3695- 3700.
  • 3Kamei M,Yamashita SI,Tokuishi K,et al. HFA expression can be asso ciated with lymph node metastases and disease-free survival in breast cancer[J]. Anticancer Research, 2010,30 (11) :4779- 4783.
  • 4Coppola D,Szabo M,Boulware D,et al. Correlation of osteopontin pro- tein expression and pathological stage across a wide variety of tumor histologies[J]. Clin Cancer Res,2004,10(1) :184-190.
  • 5Drapkin R,Horsten HH, LinY,et al. Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by se- rous and endometrioid ovarian carcinomas[J].Cancer Res,2005, 65(3):2162-2169.
  • 6Pan HW,Ou YH,Peng SY, et al. Overexpression of osteopontin is associated with intrahepatie metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma [J]. Cancer, 2003,98 ( 1 ) : 119.
  • 7Moore RG, Brown Aid, Miller MC, et al. The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass[J]. Gynecol Oncology,2008,108(2):402-408.
  • 8Israeli O,Goldring-Aviram A,Rienstein S. In silico chromosomal clustering of genes displaying altered expression patterns in ovarian Cancer[J].{H}Cancer Genetics Cytogenetics,2005,(01):35-42.
  • 9Bouchard D,Morisset D,Bourbonnais Y. Proteins with whey-acidic-protein motifs and Cancer[J].{H}LANCET ONCOLOGY,2006,(02):167-174.
  • 10Kirchhoff C. Molecular characterization of epididymal proteins[J].{H}Reviews of Reproduction,1998,(02):86-95.

引证文献7

二级引证文献80

现代妇产科进展
2010年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部